ASHLAND INC (ASH) 100.97 +0.73 (+0.73%)
100.97 +0.73 (+0.73%)
US0441861046 - Common Stock - After market: 100.97 0 (0%)
ASH May 19th Options Begin Trading
Ashland shines spotlight on inspirational women, hosts inclusion and diversity speaker, and reinforces STEM commitment for International Women’s Day
Company actions drive gender parity
Ashland downgraded to Underweight by JPMorgan on weaker demand (NYSE:ASH)
Ashland (ASH) on Thursday was downgraded to Underweight from an investment rating of Neutral by analysts at JPMorgan
Ashland Non-GAAP EPS of $0.97 beats by $0.03, revenue of $525M beats by $8.42M (NYSE:ASH)
Ashland press release (ASH): Q1 Non-GAAP EPS of $0.97 beats by $0.03.Revenue of $525M (+2.5% Y/Y) beats by $8.42M.Ashland continues to expect sales in the range of $2.5 billion to...
Ashland reports financial results1 for first quarter of fiscal year 2023 consistent with previous update
Ashland reports financial results1 for first quarter of fiscal year 2023 consistent with previous update
Sales of $525 million, up three percent from the prior-year quarterNet income (including discontinued operations) of $40 million, or $0.73 per diluted...
Ashland estimates lower-than-expected preliminary FQ1 revenues (NYSE:ASH)
Ashland (ASH) issued preliminary FQ1 results, with revenues estimated at $525M - up 3% Y/Y but lower than the current consensus estimate of $548.31M.Sales growth will be driven by...
Ashland provides update on fiscal 2023 first-quarter earnings and maintains its financial outlook for fiscal year 2023; sets date for fiscal 2023 first-quarter earnings release
WILMINGTON, Del., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today provided an update for preliminary fiscal 2023 first-quarter financial...
Ashland board authorizes quarterly dividend
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Jan. 23, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.335...
Notable Friday Option Activity: TTD, OXY, ASH
Ashland Larger Than S&P 500 Component Newell Brands
Noteworthy Tuesday Option Activity: ASH, CMRE, FRG
Ashland declares $0.335 dividend (NYSE:ASH)
Ashland (NYSE:ASH) declares $0.335/share quarterly dividend, in line with previous.Forward yield 1.21%Payable Dec. 15; for shareholders of record Dec. 1; ex-div Nov.
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Nov. 18, 2022 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.335...
Ashland board authorizes quarterly dividend
Top-Rated Ashland Stock Composite Rating Climbs On Strong Earnings
The upgrade to Ashland stock came after the specialty materials maker on Monday reported outstanding fiscal Q4 earnings.
Ashland reports financial results(1) for fourth-fiscal quarter; issues outlook for fiscal year 2023
Ashland reports financial results(1) for fourth-fiscal quarter; issues outlook for fiscal year 2023
Sales of $631 million, up 7 percent from the prior-year quarterNet income (including discontinued operations) of $57 million, or $1.04 per diluted...
Investor’s Business Daily names Ashland among 100 Best ESG Companies
WILMINGTON, Del., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has been named among the 100 Best ESG Companies by Investor’s Business Daily...
Investor’s Business Daily names Ashland among 100 Best ESG Companies
Ashland recognized with Commitment to Life Award by Natura&Co
WILMINGTON, Del., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has been recognized with the Commitment to Life Award in the Human Rights...
Ashland recognized with Commitment to Life Award by Natura&Co
Ashland earns EcoVadis Gold
Ashland earns EcoVadis Gold
WILMINGTON, Del., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has earned EcoVadis Gold underscoring the company’s commitment to...
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program
WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center...
Ashland sets date for fiscal 2022 fourth-quarter earnings release and conference call webcast
WILMINGTON, Del., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter earnings release at...